Biotechnology
RSS Feed

Structured Immunity and Medigene Announce Collaboration Aimed at Improving T Cell Receptor Development
8/21/2018 -- 8:00 AM -- Structured Immunity

American CryoStem Announces Receipt of Key Business Method Patent for its Cellular Platform
8/21/2018 -- 6:00 AM -- American CryoStem Corporation

Pressure BioSciences, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
8/15/2018 -- 8:26 AM -- Pressure BioSciences, Inc.

Pressure BioSciences, Inc. to Discuss Second Quarter 2018 Financial Results and Provide Business Update
8/10/2018 -- 9:45 AM -- Pressure BioSciences, Inc.

MorphoSys AG Reports Second Quarter 2018 Financial Results
8/1/2018 -- 4:25 PM -- MorphoSys AG

Integrated Biopharma Announces Conversion of $5,350,000 Convertible Debt to Equity
8/1/2018 -- 4:15 PM -- Integrated BioPharma, Inc.

MorphoSys to Host Q2 2018 Conference Call on August 2, 2018
7/25/2018 -- 8:30 AM -- MorphoSys AG

MorphoSys Announces Appointment of Jennifer Herron as President of MorphoSys US Inc. and Executive Vice President, Global Commercial
7/24/2018 -- 4:38 PM -- MorphoSys AG

Pressure BioSciences Developing Potential Breakthrough Processing Method for High Quality, Shelf Stable Milk and Other Dairy Products
7/19/2018 -- 9:21 AM -- Pressure BioSciences, Inc.

MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Pharma Partner
7/19/2018 -- 8:59 AM -- MorphoSys AG

Ad hoc: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Novartis and MorphoSys Increases its Financial Guidance for 2018
7/19/2018 -- 8:55 AM -- MorphoSys AG

Qrons and Dartmouth College Enter into One Year Sponsored Research Agreement
7/18/2018 -- 9:15 AM -- Qrons Inc.

DCprime and Glycotope announce licensing agreement and collaboration
7/18/2018 -- 2:50 AM -- DCprime BV

Oncolix, Inc. Forms Scientific and Clinical Advisory Board and Appoints First Member
7/17/2018 -- 7:20 AM -- Oncolix, Inc.

AcuityBio Corporation to Present at the 144th NIBA Investment Conference
7/16/2018 -- 8:00 AM -- AcuityBio Corporation

American CryoStem Announces Launch of ATGRAFT(TM) in China
7/12/2018 -- 6:00 AM -- American CryoStem Corporation

MorphoSys Announces its Licensee Janssen has Initiated a Phase 2/3 Program (GALAXI) to Evaluate Tremfya(R) (Guselkumab) in Crohn's Disease
7/10/2018 -- 4:25 PM -- MorphoSys AG

Myanmar's First Energy Service Company SIM Plans to List on TSXV Through Reverse Takeover of Verisante
7/9/2018 -- 12:00 PM -- Verisante Technology, Inc.

Oncolix, Inc. Expands Management Team with New Vice President of Corporate Development
7/5/2018 -- 7:20 AM -- Oncolix, Inc.

Calmare Therapeutics Incorporated Reports Final Tally of Consents by Shareholders of Record
7/2/2018 -- 5:35 PM -- Calmare Therapeutics Incorporated